FABRY, dRTA & HYPEROXALUREA
EPIC Pharma specialist teams have provided Medical Science Liaison, Selling and Point of Contact support for a no. of Rare Renal Disease medicines in Fabry Disease, dRTA, Cystinurea, Hyperoxalurea.
EPIC Pharma also provides MSL support for a Rare Disease medicine used to treat Bile Acid Synthesis Disorder.
This medicine was authorised under exceptional circumstances and is now withdrawn from licensed use in Europe. EPIC currently acts as a local market point of contact for all medical inquiries.
